Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol and Dorzolamide Loaded Contact Lenses for Glaucoma
NCT02852057Phase 1Completed
- Sponsor
- University of Florida
- Start
- Jan 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dorzolamide + timolol in Glaucoma, sponsored by University of Florida. Primary endpoint: Intraocular Pressure at 9 days. Started Jan 2018; status: completed.
02
Drugs
dorzolamide + timolol
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT02852057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02852057.